Evaluating Therapeutic Response to Novo-TTF

Clinical trial NCT02441322 · COMPLETED

Trial details

NCT number: NCT02441322
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2014-12-01
Primary completion: 2023-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.